#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15224	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2439	761.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1567	1567	C	929	C	929	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26032	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3940	821.9	0	.	n	.	0	T695C	SNP	695	695	T	1229	1229	C	908	C,T,A,G	904,1,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26032	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3940	821.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1871	1871	A	1059	A,T	1058,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26032	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3940	821.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2505	2505	C	915	C,T,A,G	684,229,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26032	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3940	821.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2579	2579	A	875	A,C	874,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26032	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3940	821.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3131	3131	C	921	C,G,T	919,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26032	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3940	821.9	0	HET	.	.	.	A412G,T	.	412	412	A	946	946	A	993	A,G,T	723,263,1	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2268	folP	855	855	100.0	folP.l15.c4.ctg.1	1985	142.2	1	SNP	p	R229S	0	.	.	685	687	CGC	1275	1277	CGC	214;213;214	C;G;C	214;213;214	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5662	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3654	191.9	1	SNP	p	S91F	0	.	.	271	273	TCC	688	690	TCC	238;237;235	T,G;C;C	237,1;237;235	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5662	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3654	191.9	1	SNP	p	D95G	0	.	.	283	285	GAC	700	702	GAC	236;236;237	G,A;A,T;C	234,2;235,1;237	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5662	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3654	191.9	1	SNP	p	D95N	0	.	.	283	285	GAC	700	702	GAC	236;236;237	G,A;A,T;C	234,2;235,1;237	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2134	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1905	139.7	1	SNP	p	G45D	1	.	.	133	135	GAC	845	847	GAC	240;241;241	G;A;C	240;241;241	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1206	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1517	99.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5494	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3516	194.8	1	SNP	p	D86N	0	.	.	256	258	GAC	897	899	GAC	227;230;231	G;A;C	227;230;231	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5494	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3516	194.8	1	SNP	p	S88P	0	.	.	262	264	TCC	903	905	TCC	231;231;230	T;C;C,A	231;231;229,1	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4438	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3155	175.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1819	1821	GGC	245;247;247	G;G;C,T,G	245;247;245,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1481	1483	GCA	208;210;213	G;C;A,T,G	208;210;211,1,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1484	1486	ATC	215;216;216	A,G;T,A;C,G	213,2;215,1;215,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1496	1498	GTG	222;221;220	G,T;T;G,T	220,1;220;218,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1496	1498	GTG	222;221;220	G,T;T;G,T	220,1;220;218,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2000	2002	ACC	219;220;220	A;C;C	219;220;220	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2054	2056	GCG	210;209;209	G,A,C;C,T;G,C	208,1,1;208,1;208,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2054	2056	GCG	210;209;209	G,A,C;C,T;G,C	208,1,1;208,1;208,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2177	2179	GGC	207;207;208	G;G;C,G	207;207;207,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2186	2188	GGC	202;202;202	G;G,A;C	202;200,2;202	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4060	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2872	176.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2204	2206	CTG	200;199;197	C,A;T;G,T	199,1;199;196,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5540	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3716	185.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1927	1929	CTG	224;224;221	C;T,C;G	224;223,1;221	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2580	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2164	148.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	560	562	GGC	188;189;189	G;G;C,T	188;189;188,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2580	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2164	148.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	742	742	C	194	C	194	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	S271T	NONSYN	811	813	TCG	61	63	ACT	73;73;73	A;C;T	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	67	69	GAT	73;73;73	G;A,C;T	73;72,1;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	70	72	AGT	73;73;73	A;G;T	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	D276N	NONSYN	826	828	GAT	76	78	AAC	73;73;73	A;A;C,A	73;73;72,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	N277H	NONSYN	829	831	AAC	79	81	CAC	73;73;73	C;A;C	73;73;73	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	R307E	NONSYN	919	921	AGA	169	171	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	181	183	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	E312D	NONSYN	934	936	GAA	184	186	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	190	192	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	196	198	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	202	204	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	205	207	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	208	210	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	298	porB1a	984	234	90.17	porB1a.l15.c30.ctg.2	365	32.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	214	216	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	808	810	AGC	251;248;250	A;G;C,T	251;248;249,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	900	901	CG	203;203	C;G	203;203	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	903	905	CAG	200;203;204	C;A;G,A	200;203;203,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	907	909	AAA	195;195;193	A;A;A,C	195;195;191,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	934	936	TAT	198;198;196	T;A;T	198;198;196	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	N134E	NONSYN	400	402	AAT	943	945	GAG	191;192;191	G;A;G,C	191;192;189,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	V135F	NONSYN	403	405	GTG	946	948	TTT	190;189;191	T,C;T;T	187,2;188;190	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	961	963	AAA	199;201;200	A;A;A	199;201;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	970	972	GAA	211;214;213	G;A,G,C;A	211;212,1,1;213	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	994	996	GCA	225;224;222	G;C;A	225;224;222	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	T213L	NONSYN	637	639	ACA	1180	1182	TTA	284;281;279	T;T,C,G;A	284;278,2,1;279	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	A244V	NONSYN	730	732	GCA	1273	1275	GTA	217;218;214	G;T;A,C	217;218;213,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1300	1302	CAA	183;179;178	C;A;A	183;179;177	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	.	INDELS	760	762	ACA	1304	1308	ATCAA	176;173;174;174;173	A;T;C;A;A	176;173;174;174;173	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	.	INDELS	763	764	TG	1311	1313	AGT	170;171;171	A;G,T;T	170;170,1;171	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1318	1320	GAT	168;168;168	G;A;T	168;168;168	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	V270A	NONSYN	808	810	GTA	1357	1359	GCG	202;201;198	G;C,A;G,A	202;200,1;197,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1426	1428	AGT	233;232;233	A;G;T,A	233;232;232,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	1	SNP	p	G120K	1	.	.	358	360	AAG	900	902	CGG	203;203;203	C;G;G,C	203;203;201,2	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	1	SNP	p	D121N	0	.	.	361	363	GAC	903	906	CGC	200;204;196	C;G,A;C	200;203,1;196	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2768	porB1b	1041	1041	96.47	porB1b.l6.c4.ctg.1	2148	159.9	1	SNP	p	A121D	1	.	.	361	363	GAC	903	906	CGC	200;204;196	C;G,A;C	200;203,1;196	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10004	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5365	232.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1544	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1423	135.0	1	SNP	p	V57M	1	.	.	169	171	ATG	700	702	ATG	289;289;290	A;T;G	289;289;290	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1126	1128	ACG	610;606;607	A,G;C,T,G,A;G,A	608,1;602,2,1,1;606,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1147	1149	GAC	554;551;550	G,A;A;C,G	552,1;551;549,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1165	1167	ATG	545;545;542	A;T,G;G,T	545;544,1;541,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1177	1179	TCA	538;535;539	T;C,A;A,G	538;534,1;538,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1222	1224	CAG	512;505;500	C,T;A,G;G,T,A	511,1;504,1;498,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1243	1245	CTT	461;463;462	C,T,G;T,G;T,C,A	458,2,1;461,2;460,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1264	1266	AGT	467;467;465	A,C;G,C,A;T	466,1;465,1,1;465	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1333	1335	CCG	487;491;491	C;C,T,A;G,A	487;489,1,1;490,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1435	1437	TCG	618;616;610	T;C;G,C,A	618;615;607,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1606	1608	AAA	257;254;249	A;A;A	257;253;248	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1609	1611	AAG	245;246;242	A,T;A;G	244,1;246;242	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1624	1626	CAC	237;240;243	C;A;C	237;240;243	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1663	1665	GAA	317;319;320	G;A,G;A	317;318,1;320	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1741	1743	ACG	423;426;425	A,C,G;C;G	420,1,1;425;424	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1792	1794	ATT	506;508;511	A,T,G;T;T	504,1,1;508;511	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1795	1797	AGT	512;510;510	A,T;G,T;T,G	511,1;509,1;509,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1834	1836	CTA	541;539;540	C,A;T;A,T,C	538,3;539;538,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1876	1878	AAT	523;524;521	A,C;A;T	518,1;520;521	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1945	1947	TCA	479;477;474	T;C,A;A	479;476,1;474	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1969	1971	ATG	460;460;459	A;T;G	460;460;459	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2263	2265	ACC	588;585;589	A,T,G;C,G;C,T	586,1,1;584,1;588,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11008	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3136	437.5	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2359	2361	GAA	537;532;529	G;A;A	536;532;529	.	Tetracycline resistance
